InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001209191-22-012844 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-24 2022-02-22 RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +100.0K 334.0K +43% $0
D 2022-02-24 2022-02-22 RXRX Gibson Christopher CEO, Dir S - Sale $10.22 -100.0K 234.0K -30% -$1.02M
D 2022-02-24 2022-02-22 RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -100.0K 7.66M -1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-02-22 C A 100,000 $0.00 334,020 D — — (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
2 Common Class A Common Stock 2022-02-22 S D 100,000 $10.22 234,020 D — — (F4) This transaction was executed in multiple trades at prices ranging from $9.91 to $10.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Derivative Class B Common Stock 2022-02-22 C D 100,000 $0.00 7,658,484 D $0.00 · — to — 7,658,484 Class A Common Stock (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.